Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
Table 2
Laboratory characteristics of all patients according to outcome.
Characteristics
All patients
Survivors
Nonsurvivors
value
WBC count (109/L)
12.74 ± 5.59
12.91 ± 5.31
12.53 ± 5.91
Neutrophil (109/L)
10.40 (7.32–13.42)
10.30 (7.30–13.75)
10.40 (7.40–13.05)
Lymphocyte (109/L)
0.95 (0.61–1.31)
1.06 (0.77–1.45)
0.81 (0.55–1.20)
Monocyte (109/L)
0.60 (0.35–0.92)
0.64 (0.40–1.03)
0.56 (0.29–0.80)
Platelet (109/L)
241.63 ± 152.29
267.41 ± 156.04
210.94 ± 142.15
MPV (fL)
9.05 ± 1.76
8.61 ± 1.27
9.61 ± 2.11
MPV/PC ratio (fL 10−5μL−1)
3.7 (2.5–6.2)
3.4 (2.3–5.3)
4.7 (3.0–8.0)
NLR
11.00 (7.02–15.71)
9.91 (6.17–13.78)
12.26 (7.72–18.25)
MLR
0.61 (0.38–1.02)
0.62 (0.37–1.02)
0.58 (0.39–1.01)
PLR
226.53 (162.16–354.20)
228.38 (152.71–328.59)
225.11 (166.47–410.40)
Data are shown as number (%), mean (standard deviation, SD), or median (interquartile range, IQR) as appropriate. Significant differences are marked by ().
